Intech Investment Management LLC Has $12.01 Million Stake in Tenet Healthcare Corporation $THC

Intech Investment Management LLC lessened its position in Tenet Healthcare Corporation (NYSE:THC) by 54.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,152 shares of the company’s stock after selling 69,371 shares during the period. Intech Investment Management LLC’s holdings in Tenet Healthcare were worth $12,010,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare in the third quarter valued at approximately $32,000. Westside Investment Management Inc. grew its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont acquired a new position in Tenet Healthcare in the 3rd quarter valued at approximately $41,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare during the second quarter worth $35,000. Finally, True Wealth Design LLC grew its stake in shares of Tenet Healthcare by 238.2% in the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after purchasing an additional 181 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $239.73 on Friday. The stock has a market capitalization of $20.85 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 1.15 and a beta of 1.44. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $240.83. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The stock’s 50 day moving average price is $205.17 and its two-hundred day moving average price is $199.24.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company’s stock, valued at $5,623,945.60. The trade was a 7.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.81% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on THC. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Leerink Partners lifted their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. Truist Financial increased their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. JPMorgan Chase & Co. boosted their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $247.67.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.